Likewise, dracorhodin (a flavonoid from Dragon’s Blood) improved DFU outcomes via multi-pathway modulation: it dose-dependently enhanced collagen deposition and angiogenesis while reducing inflammatory cytokines (TNF-α, IL-6) and ROS levels in a diabetic foot ulcer model [22]. This evidence concerns the gene TNF and diabetic foot.